Danaher Invests in AI Healthcare Company

Dow Jones
2025/01/10

By Connor Hart

Two Danaher subsidiaries have formed what the company called an investment partnership with Innovaccer, a healthcare artificial-intelligence company.

The partnership aims to improve patient outcomes and experiences through novel digital and diagnostic solutions, the companies said Thursday. It will additionally seek to accelerate the adoption of precision diagnostics by clinicians and population health teams.

Terms of the partnership weren't disclosed.

Innovaccer builds software that creates a unified patient record, which the company said allows it to use AI to identify gaps in care and patients who are at risk, as well as appropriate interventions to improve outcomes.

Washington, D.C.-based Danaher said the investment aligns with its mission to accelerate the transition to precision medicine with AI-enabled diagnostics.

Before the market closed Innovaccer said it raised $275 million in a Series F funding round. Investors included B Capital Group, Banner Health, Danaher Ventures LLC, Generation Investment Management, Kaiser Permanente and M12.

Write to Connor Hart at connor.hart@wsj.com

 

(END) Dow Jones Newswires

January 09, 2025 16:47 ET (21:47 GMT)

Copyright (c) 2025 Dow Jones & Company, Inc.

应版权方要求,你需要登录查看该内容

免责声明:投资有风险,本文并非投资建议,以上内容不应被视为任何金融产品的购买或出售要约、建议或邀请,作者或其他用户的任何相关讨论、评论或帖子也不应被视为此类内容。本文仅供一般参考,不考虑您的个人投资目标、财务状况或需求。TTM对信息的准确性和完整性不承担任何责任或保证,投资者应自行研究并在投资前寻求专业建议。

热议股票

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10